On the basis of product, the wound debridement market is segmented into gels, ointments & creams, surgical devices, ultrasound devices, mechanical debridement pads, medical gauzes, and other wound debridement products. Ultrasonic devices are expected to grow at the highest CAGR during the forecast period due to advantages such as their ability to differentiate between viable and non-viable tissue and their ability to destroy bacteria and biofilms without damaging blood vessels.
Based on wound type, the wound debridement market has been segmented into venous leg ulcers (VLUs), diabetic foot ulcers (DFUs), pressure ulcers, surgical & traumatic wounds, burns, and other wounds. The diabetic foot ulcers segment is expected to register the highest CAGR during the forecast period, primarily due to the increasing prevalence of diabetes globally.
Based on end user, the wound debridement market has been segmented into hospitals, clinics, and other end users. In 2018, the hospitals segment is estimated to account for the largest market share. The availability of infrastructure and the presence of skilled professionals in hospitals are the major driving factors for this segment.
Geographically, the wound debridement market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Asia Pacific is estimated to register the highest growth rate during the forecast period. Growth in this market is driven by the presence of a large patient population and increasing awareness regarding advanced healthcare products.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
